The 25 best gadgets we saw at CES 2025, from next-gen TVs to better portable gaming to a smart grill
CES always brings a rich new wave of cool products, and we’ve been hunting them down
Related Articles
105th Annual Meeting
Late Breaking Prospective Clinical Trial abstracts are targeted toward randomized clinical trial data, large population-based trial evidence, or novel translational evidence that is likely to…
Kaneka Acquires EndoStream Medical – Endovascular Today
January 9, 2025—Kaneka Corporation announced that it acquired 96.8% of the shares of EndoStream Medical Ltd. (ESM) on December 23, 2024. ESM,
Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients With a Low Risk for Arrhythmic Death (CONTEMP-ICD)
The project title and summary on this page were provided by and reflect the opinions and work of the awardee and do not necessarily represent…
Call For Applications | ACC 2026 Leadership Forum Chair – American College of Cardiology
Call For Applications | ACC 2026 Leadership Forum Chair
Tricuspid valve complication following leadless pacemaker implantation requiring device extraction
The last decade has seen growing interest in leadless cardiac pacing systems. The appeal of leadless pacemaker (LP) implantation is potentially avoiding complications associated with…
Intravascular Hemolysis Related to Pulsed Field Ablation
Introduction of this new energy source and the associated electrode catheters designed to deliver PFA has come with the recognition of novel procedural risks and…
New CPT Code 0932T for Noninvasive Detection of Heart Failure
Effective January 1, 2025, the new CPT code 0932T – Noninvasive detection of heart failure derived from augmentative analysis of an echocardiogram that demonstrated preserved…
Outcomes of Transseptal Mitral Valve-in-Valve in Patients With Intermediate Surgical Risk
S. Chris Malaisrie, MD, cardiac surgeon, discusses the one-year outcomes of the PARTNER 3 Mitral Valve in Valve (MViV) clinical trial.The trial is investigat…
Granulocyte colony-stimulating factor for stem cell mobilisation in acute myocardial infarction: a randomised controlled trial
Background To determine whether granulocyte colony-stimulating factor (G-CSF) improves clinical outcomes after large ST-elevation myocardial infarction (STEMI) when administered early in patients with left ventricular…
